These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32163785)

  • 21. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E; Fogler JM; Hammerness PG
    JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Prevention: Tic Disorders.
    Stiede JT; Woods DW
    Pediatr Clin North Am; 2020 Jun; 67(3):547-557. PubMed ID: 32443993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of tic-disorders].
    Roessner V; Banaschewski T; Rothenberger A
    Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):245-63. PubMed ID: 15565895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based treatment of Tourette's disorder and chronic tic disorders.
    Essoe JK; Grados MA; Singer HS; Myers NS; McGuire JF
    Expert Rev Neurother; 2019 Nov; 19(11):1103-1115. PubMed ID: 31295410
    [No Abstract]   [Full Text] [Related]  

  • 26. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized waitlist-controlled pilot trial of voice over Internet protocol-delivered behavior therapy for youth with chronic tic disorders.
    Ricketts EJ; Goetz AR; Capriotti MR; Bauer CC; Brei NG; Himle MB; Espil FM; Snorrason Í; Ran D; Woods DW
    J Telemed Telecare; 2016 Apr; 22(3):153-62. PubMed ID: 26169350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and safety of aripiprazole in the treatment of childhood tic disorders: a Meta analysis].
    Fang Q; Chen L; Chen QB; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jul; 17(7):715-20. PubMed ID: 26182278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
    Jain R; Katic A
    Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic treatment of tic disorders.
    Scahill L; Chappell PB; King RA; Leckman JF
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):99-117. PubMed ID: 10674192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Habit Reversal Training in Children With Chronic Tic Disorders: A Within-Subject Analysis.
    Viefhaus P; Feldhausen M; Görtz-Dorten A; Volk H; Döpfner M; Woitecki K
    Behav Modif; 2020 Jan; 44(1):114-136. PubMed ID: 30146896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders.
    Ghanizadeh A
    Neurosciences (Riyadh); 2012 Jul; 17(3):200-4. PubMed ID: 22772923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole for autism spectrum disorders (ASD).
    Hirsch LE; Pringsheim T
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009043. PubMed ID: 27344135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.
    Weisman H; Qureshi IA; Leckman JF; Scahill L; Bloch MH
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1162-71. PubMed ID: 23099282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders.
    Murphy TK; Fernandez TV; Coffey BJ; Rahman O; Gavaletz A; Hanks CE; Tillberg CS; Gomez LI; Sukhodolsky DG; Katsovich L; Scahill L
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):762-770. PubMed ID: 28723227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.